Headline Leads Blossom Health’s Series A

Gunderson Dettmer represented Headline, a global venture capital firm that partners with fast-growing technology companies, as the lead investor in the Series A financing of Blossom Health, the leading all-in-one AI operating system for psychiatry. To date, Blossom Health has raised $20 million in total funding across its seed and Series A rounds.

Headline’s investment in Blossom Health will help the company expand its state coverage, contract with national and regional health insurance payors, onboard more providers, as well as invest in R&D to accelerate its frontier applied-AI technology.

“Blossom is addressing one of the most urgent and consequential challenges in modern healthcare with extraordinary focus and technological depth," said Mathias Schilling, Co-Founder and Managing Partner of Headline, in the announcement of the transaction. “Their AI operating system is not just improving access to psychiatric care-it's fundamentally redefining how clinicians practice and how patients heal. We believe Blossom has the potential to become the technological backbone of modern mental health, bridging the gap between overwhelming demand and limited clinical supply.”

The Gunderson deal team was led by Zach Crowe and included Jasmine Daniel.

Companies
Headline
Blossom Health